FONR fonar.com: Multiplikator Forward P/S

Logo grafis FONAR Corp (FONR)

Stable service revenue and software updates support the business maturity of FONAR Corporation (FONR), as reflected in the issuer's forward P/S dynamics. The 1.10 mark characterizes this parameter. A monopoly on vertical magnets eliminates direct competition, while partnerships with clinics specializing in natural-position spinal examinations improve diagnostics. This ensures the stability of the company's market value.

fonar.com - Rasio kapitalisasi marang dodolan sing dikarepake FONR (periode 04.07.2022 - 13.06.2026)

Rincian metrik lan analitis perusahaan fonar.com (FONR)

- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
Ringkesan analitik perusahaan:FONAR Corp (FONR)
Sampel barang FONAR Corporation

A conservative investor evaluates the ratio of current market capitalization to projected revenue to determine the extent of overpayment for future cash flows. By analyzing the forward price-to-sales valuation trend, one can understand to what extent the market has priced in the uniqueness of FONAR Corporation (FONR) vertical MRI systems, ensuring a long-term balance between the technological advantage in spinal diagnostics and the fair market value of the shares.

Pesaing wigati

Multiplikator Forward P/S ABT (Abbott Laboratories)|TMO: Kapitalisasi marang prakiraan pendapatan|GE HealthCare Technologies - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Mettler-Toledo International MTD|WAT: Multiplikator Forward P/S|TECH - Rasio kapitalisasi marang dodolan sing dikarepake|BRKR (Bruker BioSpin) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Azenta Life Sciences (AZTA)|Multiplikator Forward P/S VREX|Multiplikator Forward P/S semlerscientific.com (SMLR)|Rasio rega marang prakiraan pendapatan Butterfly Network BFLY|Mesa Labs Corp - Rasio rega marang prakiraan pendapatan|quantum-si.com - Multiplikator Forward P/S|Rega forward marang dodolan NNOX (Nanox)|QTRX: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep 908devices.com (MASS)|CV (CapsoVision) - Multiplikator Forward P/S|MXCT - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan RPID (rapidmicrobio.com)|Multiplikator Forward P/S Seer Inc. (SEER)|Multiplikator Forward P/S HYPR (hyperfine.io)|DXR (Daxor Corporation) - Rega mangsa ngarep marang pendapatan|MDAI - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan VIVS|Aclarion Corporation (ACON) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Akoya Biosciences Inc|THMO (ThermoGenesis Holdings, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep talis.bio TLIS|Rasio rega marang prakiraan pendapatan T2 Biosystems, Inc (TTOO)